Admin_Core
管理核心
基本信息
- 批准号:10663327
- 负责人:
- 金额:$ 34.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvanced Malignant NeoplasmCancer SurvivorCaregiversCaringClinicalCollaborationsCommunicationCommunitiesContinuity of Patient CareData AnalysesData CollectionDevelopmentDisciplineDisparityEducationEffectivenessEnsureEnvironmentEquityEvaluationFacultyFundingGuidelinesHealth PersonnelHealthcareInfrastructureInstitutional Review BoardsInterdisciplinary StudyInterventionJournalsKnowledgeLeadershipLicensingMalignant NeoplasmsManuscriptsMeasuresMethodologyMissionMonitorNational Cancer InstituteOutcomePatient advocacyPatientsPeer ReviewPennsylvaniaPoliciesPolicy MakerPositioning AttributePostdoctoral FellowProcessProfessional OrganizationsPublicationsQuality of CareResearchResearch MethodologyResearch PersonnelResourcesScienceSeriesService delivery modelSumTechnologyTestingUniversitiesVisionaccess disparitiesadvocacy organizationsbehavioral economicscancer carecare deliverycareercareer developmentclinical careclinical practicedesignevidence baseexperiencegraduate studenthealth care deliveryhealth care modelhealth disparityhealth equityimprovedinnovationinsightpatient orientedpragmatic trialsuccesssymposiumsynergismtelehealthtelehealthcarevisiting scholar
项目摘要
PROJECT SUMMARY/ABSTRACT (ADMINISTRATIVE CORE)
The objective of the Administrative Core of the University of Pennsylvania Telehealth Research Center in
Cancer Care (Penn TRC) is to ensure that the impact of the Center is greater than the sum of its parts. The
Administrative Core will accomplish this objective by maximizing collaboration and synergy across the
Research and Methods Core, Clinical Practice Network, and Pragmatic Trial. The Penn TRC’s cohesive
organizing framework addresses the fundamental question of how to leverage insights from communication
science and behavioral economics to design and test innovative telehealth strategies for care delivery to
improve effectiveness and equity across the cancer care continuum, with an emphasis on understanding
mechanisms of action. The Administrative Core will provide overarching strategic, operational, and scientific
oversight to achieve this organizing framework. The specific aims of the Administrative Core are to: 1) Provide
essential leadership and integration of all Penn TRC activities; 2) Create interdisciplinary research capacity
and collaborations; 3) Coordinate communication and dissemination of research findings, evidence-based
telehealth strategies, care delivery models, and other resources to scientific audiences and other relevant
stakeholders; and 4) Monitor and evaluate Penn TRC progress and leverage findings to inform iterative
refinement of Penn TRC activities and plans for future research. Completion of these aims will create a culture
of exceptional interdisciplinary science and ensure success by stimulating and guiding new methodological
advancements, building capacity for cancer care delivery research, and generating a robust evidence base for
patient-centered, sustainable telehealth models of care at Penn and nationally. The Administrative Core
leadership will ensure that the Penn TRC fulfills the National Cancer Institute’s vision to advance a national
telehealth research agenda focused on improving cancer-related care and outcomes across the cancer care
continuum in a rapidly changing health care, policy, technology, and communication environment.
项目摘要/摘要(行政核心)
宾夕法尼亚大学远程医疗研究中心行政核心的目标
癌症护理(Penn TRC)是为了确保中心的影响大于其部分的总和。这
行政核心将通过最大化协作和协同作用来实现这一目标
研究和方法核心,临床实践网络和务实试验。 Penn TRC的凝聚力
组织框架解决了如何利用沟通见解的基本问题
科学和行为经济学设计和测试创新的远程医疗策略,以提供护理的交付
提高癌症护理连续性的有效性和平等,重点是理解
作用机理。行政核心将提供总体的战略,运营和科学
实现这个组织框架的监督。行政核心的具体目的是:1)提供
所有Penn TRC活动的基本领导和整合; 2)创建跨学科研究能力
和合作; 3)协调研究结果的沟通和传播,基于证据
远程医疗策略,护理交付模型和其他资源给科学受众和其他相关的受众
利益相关者; 4)监视和评估Penn TRC的进度并利用发现以告知迭代
Penn TRC活动和未来研究计划的完善。这些目标的完成将创造一种文化
具有卓越的跨学科科学,并通过刺激和指导新方法来确保成功
进步,建立癌症护理提供研究能力,并为
宾夕法尼亚州和全国性的以患者为中心的可持续远程医疗护理模型。行政核心
领导力将确保宾夕法尼亚州TRC履行国家癌症研究所的愿景
远程医疗研究议程的重点是改善癌症护理中与癌症相关的护理和结果
在迅速变化的医疗保健,政策,技术和沟通环境中连续。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Justin Bekelman其他文献
Justin Bekelman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Justin Bekelman', 18)}}的其他基金
Advancing cancer care and equity through telehealth, communication science, and behavioral economics
通过远程医疗、传播科学和行为经济学促进癌症护理和公平
- 批准号:
10453882 - 财政年份:2022
- 资助金额:
$ 34.62万 - 项目类别:
Advancing cancer care and equity through telehealth, communication science, and behavioral economics
通过远程医疗、传播科学和行为经济学促进癌症护理和公平
- 批准号:
10663326 - 财政年份:2022
- 资助金额:
$ 34.62万 - 项目类别:
Markers of Cardiotoxicity with Radiation Therapy in Breast Cancer
乳腺癌放射治疗的心脏毒性标志物
- 批准号:
10401906 - 财政年份:2020
- 资助金额:
$ 34.62万 - 项目类别:
Markers of Cardiotoxicity with Radiation Therapy in Breast Cancer
乳腺癌放射治疗的心脏毒性标志物
- 批准号:
10249141 - 财政年份:2020
- 资助金额:
$ 34.62万 - 项目类别:
Markers of Cardiotoxicity with Radiation Therapy in Breast Cancer
乳腺癌放射治疗的心脏毒性标志物
- 批准号:
10613352 - 财政年份:2020
- 资助金额:
$ 34.62万 - 项目类别:
Effectiveness of Radiotherapy for Prostate Cancer
前列腺癌放射治疗的有效性
- 批准号:
8701251 - 财政年份:2012
- 资助金额:
$ 34.62万 - 项目类别:
Effectiveness of Radiotherapy for Prostate Cancer
前列腺癌放射治疗的有效性
- 批准号:
8383228 - 财政年份:2012
- 资助金额:
$ 34.62万 - 项目类别:
Effectiveness of Radiotherapy for Prostate Cancer
前列腺癌放射治疗的有效性
- 批准号:
8899458 - 财政年份:2012
- 资助金额:
$ 34.62万 - 项目类别:
Effectiveness of Radiotherapy for Prostate Cancer
前列腺癌放射治疗的有效性
- 批准号:
8532663 - 财政年份:2012
- 资助金额:
$ 34.62万 - 项目类别:
相似海外基金
Project: Survivorship Care Physical Activity Initiative to Improve Disparities in HRQoL for Prostate Cancer Survivors (RELate Study)
项目:旨在改善前列腺癌幸存者 HRQoL 差异的生存护理体力活动计划(RELate 研究)
- 批准号:
10911646 - 财政年份:2023
- 资助金额:
$ 34.62万 - 项目类别:
Evaluating the relationship between immune checkpoint inhibitors and osteoarthritis
评估免疫检查点抑制剂与骨关节炎之间的关系
- 批准号:
10577306 - 财政年份:2023
- 资助金额:
$ 34.62万 - 项目类别:
Addressing Genomic Disparities in Cancer Survivors
解决癌症幸存者的基因组差异
- 批准号:
10813426 - 财政年份:2023
- 资助金额:
$ 34.62万 - 项目类别: